GUAN Qingxia, LUO Yuting, LIU Yumeng, LI Ying, YANG Han, LI Minan, LI Xiuyan. Application and Progress of Artificial Intelligence in Development of Anti-tumor Drugs[J]. Chinese Journal of Modern Applied Pharmacy, 2023, 40(23): 3318-3323. DOI: 10.13748/j.cnki.issn1007-7693.20230857
    Citation: GUAN Qingxia, LUO Yuting, LIU Yumeng, LI Ying, YANG Han, LI Minan, LI Xiuyan. Application and Progress of Artificial Intelligence in Development of Anti-tumor Drugs[J]. Chinese Journal of Modern Applied Pharmacy, 2023, 40(23): 3318-3323. DOI: 10.13748/j.cnki.issn1007-7693.20230857

    Application and Progress of Artificial Intelligence in Development of Anti-tumor Drugs

    • With the rapid development of artificial intelligence and the gradual deepening of people's understanding of the mechanisms of tumor diseases, artificial intelligence has played an important role in the research and development of anti-tumor drugs. This article briefly introduces the main models of artificial intelligence and its advantages in drug research and development, and summarizes the application and progress of artificial intelligence in anti-tumor drug research and development in recent years from four aspects: structure based, ligand based, tumor cell phenotype, and electronic health records. It also summarizes the opportunities and challenges of artificial intelligence in anti-tumor drug research and development, hoping to provide ideas and references for scientific and technical personnel engaged in related fields.
    • loading

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return